Genomic and Phylogenetic Analysis of Zika Virus Isolates from Asymptomatic Blood Donors in the United States and Puerto Rico, 2016.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 12 2 2020
medline: 24 6 2020
entrez: 12 2 2020
Statut: ppublish

Résumé

Zika virus (ZIKV) caused a public health threat in the United States in 2016, leading to rapid development and implementation of blood screening assays for ZIKV RNA. Several ZIKV sequences from clinical cases have been reported, but none from asymptomatic/pre-symptomatic infections. We isolated and sequenced ZIKV from asymptomatic/pre-symptomatic blood donor (ABD-ZIKV) samples and compared with reported clinical sequences. Twelve ABD-ZIKV isolates were produced from 67 cultivated samples, and isolates were genetically similar among themselves. Most isolates shared mutations with the clinical isolate PRVABC59 2015, whereas two ABD-ZIKV isolates shared specific mutations with U.S. clinical isolates from 2016. The ABD-ZIKV strains clustered into two distinct subclades: one comprised mostly ABD-ZIKV from Puerto Rico, and another one comprised ABD-ZIKV from Florida and QTX-02 isolate (Puerto Rico). In this study, we showed the circulation of two slightly distinct virus strains among Puerto Rico blood donors, one of which was also reported in Florida.

Identifiants

pubmed: 32043455
doi: 10.4269/ajtmh.19-0747
pmc: PMC7124893
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

880-883

Références

Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
N Engl J Med. 2016 Sep 15;375(11):1101-3
pubmed: 27532622
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):569-72
pubmed: 26061233
MMWR Morb Mortal Wkly Rep. 2016 Mar 25;65(11):286-9
pubmed: 27023833
J Virol. 2010 Jan;84(2):765-72
pubmed: 19889759
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Trends Microbiol. 2016 Jul;24(7):521-522
pubmed: 27220937
Virol Sin. 2016 Apr;31(2):118-30
pubmed: 27129451
Am J Public Health. 2016 Apr;106(4):601-5
pubmed: 26959259
Science. 2016 Apr 15;352(6283):345-349
pubmed: 27013429
Blood. 2017 Jan 12;129(2):263-266
pubmed: 27827826
Emerg Infect Dis. 2014 Jun;20(6):1085-6
pubmed: 24856001
Nature. 2017 Jun 15;546(7658):411-415
pubmed: 28538734
Emerg Infect Dis. 2015 Oct;21(10):1887
pubmed: 26403318
Viruses. 2019 Nov 14;11(11):
pubmed: 31739467
Nature. 2017 Jun 15;546(7658):401-405
pubmed: 28538723
Transfusion. 2016 Jul;56(7):1684-8
pubmed: 27329551

Auteurs

Felipe Lopes Assis (FL)

Division of Emerging and Transfusion Transmitted Diseases (DETTD), Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland.

Emilia Sippert (E)

Division of Emerging and Transfusion Transmitted Diseases (DETTD), Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland.

Bruno Coelho Rocha (BC)

Division of Emerging and Transfusion Transmitted Diseases (DETTD), Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland.

Evgeniya Volkova (E)

Division of Emerging and Transfusion Transmitted Diseases (DETTD), Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland.

Rafaelle Fares-Gusmao (R)

Division of Emerging and Transfusion Transmitted Diseases (DETTD), Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland.

Suzan Ok (S)

Division of Emerging and Transfusion Transmitted Diseases (DETTD), Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland.

Caren Chancey (C)

Division of Emerging and Transfusion Transmitted Diseases (DETTD), Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland.

Maria Rios (M)

Division of Emerging and Transfusion Transmitted Diseases (DETTD), Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH